ViiV, Pfizer and Roche top pharmas on corporate reputation according to patient groups

juststock/iStock via Getty Images ViiV Healthcare, Pfizer (NYSE:PFE), Roche (OTCQX:RHHBY) — in that order — are the three most favorably viewed pharmaceutical companies based on a survey of patient groups. ViiV is majority owned by GlaxoSmithKline (NYSE:GSK) In its report, “The Corporate Reputation of Pharma in 2021,” research and consultancy firm PatientView surveyed 2,150 patient groups. 59% of the groups said the industry had an excellent or good corporate reputation. The top three “big pharma” companies among 13 were Pfizer (PFE), Roche (OTCQX:RHHBY), and Johnson and Johnson’s (NYSE:JNJ) Janssen unit.